Excellent post RVXoldtimer. Same principle for any money flowing into Zenith from the Resverlogix Royalty Preferred Shares. These royalties would flow into ZCC with the decision to dividend some or all to Zenith shareholders being left to the Board. One benefit of listing Zenith Epigenetics Ltd (ZEL) sooner rather than later is that every time Zenith issues shares right now, the new shareholders are getting shares of ZCC. This effectively dilutes the potential value of the Royalty Preferred Shares. Once ZEL gets listed (or sold separately from ZCC) then any future dilution of ZEL won't dilute ZCC and the Royalty Preferred Shares.

BearDownAZ